A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2004
12/01/2004	EP1480996A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
12/01/2004	EP1480980A2 Syntheses of quinazolinones
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480964A1 Inhibiteurs de l'angiogenese
12/01/2004	EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
12/01/2004	EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480951A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
12/01/2004	EP1480688A1 N-(5- 4-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine coated stents
12/01/2004	EP1480682A1 Coupling proteins to a modified polysaccharide
12/01/2004	EP1480666A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
12/01/2004	EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1261355B1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1121449A4 Delivery system for porcine somatotropin
12/01/2004	EP1056462A4 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/01/2004	EP0994697B1 Rapamycin formulations for oral administration
12/01/2004	EP0852501B1 Use of hyaluronic acid as an immunosuppressant
12/01/2004	EP0551401B2 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
12/01/2004	CN1551881A Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
12/01/2004	CN1551877A Piperidine derivatives useful as CCR5 antagonists
12/01/2004	CN1551783A Method for treating multiple myeloma
12/01/2004	CN1551779A Osteogenis oligopeptide as blood-formation stimulation articles
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551766A Lymphocytic activation inhibitor and remedial agent for autoimmune disease
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550236A Protein stability in aqueous solution
12/01/2004	CN1550235A Use of heparin-binding antagonists in the inhibition of bradykinin release
12/01/2004	CN1550232A Use of heterocyclic amide in production of autoimmune diseases inhibitors
12/01/2004	CN1177860C Cholenic acid amides and pharmaceutical compositions thereof
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177834C Dihydroxyhexanoic acid derivatives
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177613C Chemokine receptor antagonist and ocyclosporin in combined therapy
12/01/2004	CN1177610C Pharmaceutical composition for immunomodulation based on peptides and adjuvants
11/2004
11/30/2004	US6825360 Bicyclic aromatic compounds
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825350 Administering dosage of immunology response moderator
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825190 Protein kinase inhibitors and uses thereof
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824786 Topical applying cosmetic
11/30/2004	US6824773 TWEAK receptor
11/30/2004	CA2305307C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
11/30/2004	CA2298245C Matrix controlled release device
11/25/2004	WO2004101776A2 Novel uses of ppar modulators and professional apcs manipulated by the same
11/25/2004	WO2004101551A1 Crystal of benzimidazole derivative and process for producing the same
11/25/2004	WO2004101514A1 Cyanofluoropyrrolidine derivative
11/25/2004	WO2004100966A1 Preparation for preventing contact of pathogenic matter with living organism
11/25/2004	WO2004100965A1 Immunostimulant
11/25/2004	WO2004100961A1 Sulfate group transferase inhibitor
11/25/2004	WO2004100868A2 Method of treating transplant rejection
11/25/2004	WO2004093898A3 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/25/2004	WO2004087747A3 Citrullinated synthetic peptides and uses thereof
11/25/2004	WO2004082681B1 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
11/25/2004	WO2004069272A3 Adjuvant combination for use in the immunization of a mamal comprising il2 and il12
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	WO2003082924A8 Immunotherapeutic and immunoprophylactic reagents
11/25/2004	US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders
11/25/2004	US20040236116 Novel bicyclic and tricyclic cannabinoids
11/25/2004	US20040236108 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO); treat an inflammatory disease or condition, related to carbohydrate metabolism, smooth muscle cell function; chemical synthesis
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236076 Polyclonal IgY compound from eggs of transgenic SPF-chickens with constant regions of human IgG and additionally consist of at least one signal and/or active agent and/or booster molecule; for treating noninfectious inflammations, infectious diseases, clotting disorders, autoimmune diseases and cancer
11/25/2004	US20040235943 Triptolide derivatives for modulation of apoptosis and immunosuppression
11/25/2004	US20040235938 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235890 Remedies for allergic diseases
11/25/2004	US20040235873 foods and drinks, animal feeds or adjuvants comprising orotic acid and/or salts, used as antiallergens
11/25/2004	US20040235866 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235834 For therapy and prophylaxis of immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, proliferative disorders, immunologically-mediated diseases, or respiratory disorders
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235782 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/25/2004	US20040235770 Topically administered to treat cancer and infections
11/25/2004	US20040235767 Synergistic mixture comprises cell adhesion molecule or a mammalian expression vector containing DNA; gene therapy; antitumor agents

1 ... 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 ... 1172